Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhashini Jagu

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Pediatrics|December 19, 2024
The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatmentSubhashini Jagu, Jaime M Guidry Auvil, Gregory Reaman
Vaccine|May 4, 2010
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infectionSubhashini Jagu, Kihyuck Kwak, Robert L Garcea, et al.
Immunology and Cell Biology|May 8, 2009
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infectionBalasubramanyam Karanam, Subhashini Jagu, Warner K Huh, et al.
Virology Journal|October 29, 2009
Role of L2 cysteines in papillomavirus infection and neutralizationRatish Gambhira, Subhashini Jagu, Balasubramanyam Karanam, et al.
Plos One|May 13, 2014
Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus typesKihyuck Kwak, Rosie Jiang, Joshua W Wang, et al.
Virology|January 15, 2014
Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studiesJoshua W Wang, Subhashini Jagu, Kihyuck Kwak, et al.
Plos One|February 6, 2013
Optimization of multimeric human papillomavirus L2 vaccinesSubhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, et al.
Plos One|March 29, 2013
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporationKihyuck Kwak, Rosie Jiang, Subhashini Jagu, et al.
Journal of Virology|August 24, 2007
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2Ratish Gambhira, Subhashini Jagu, Balasubramanyam Karanam, et al.
Cell Host & Microbe|September 14, 2010
In vivo mechanisms of vaccine-induced protection against HPV infectionPatricia M Day, Rhonda C Kines, Cynthia D Thompson, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Pediatrics|December 19, 2024
The childhood cancer data initiative: enabling data sharing to drive research advances and transform pediatric cancer diagnosis and treatmentSubhashini Jagu, Jaime M Guidry Auvil, Gregory Reaman
Vaccine|May 4, 2010
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infectionSubhashini Jagu, Kihyuck Kwak, Robert L Garcea, et al.
Immunology and Cell Biology|May 8, 2009
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infectionBalasubramanyam Karanam, Subhashini Jagu, Warner K Huh, et al.
Virology Journal|October 29, 2009
Role of L2 cysteines in papillomavirus infection and neutralizationRatish Gambhira, Subhashini Jagu, Balasubramanyam Karanam, et al.
Plos One|May 13, 2014
Impact of inhibitors and L2 antibodies upon the infectivity of diverse alpha and beta human papillomavirus typesKihyuck Kwak, Rosie Jiang, Joshua W Wang, et al.
Virology|January 15, 2014
Preparation and properties of a papillomavirus infectious intermediate and its utility for neutralization studiesJoshua W Wang, Subhashini Jagu, Kihyuck Kwak, et al.
Plos One|February 6, 2013
Optimization of multimeric human papillomavirus L2 vaccinesSubhashini Jagu, Kihyuck Kwak, Balasubramanyam Karanam, et al.
Plos One|March 29, 2013
Multivalent human papillomavirus l1 DNA vaccination utilizing electroporationKihyuck Kwak, Rosie Jiang, Subhashini Jagu, et al.
Journal of Virology|August 24, 2007
Protection of rabbits against challenge with rabbit papillomaviruses by immunization with the N terminus of human papillomavirus type 16 minor capsid antigen L2Ratish Gambhira, Subhashini Jagu, Balasubramanyam Karanam, et al.
Cell Host & Microbe|September 14, 2010
In vivo mechanisms of vaccine-induced protection against HPV infectionPatricia M Day, Rhonda C Kines, Cynthia D Thompson, et al.
Pageof 4